Argentina’s population numbers about 40 million, with main genetic contributions from Europeans, Amerindians and, to a much lower extent, West Africans. There is a traditional health care system publicly funded coexisting with a social security system and a for-profit private sector. Clinical genetic services include about 40 units in public hospitals dealing mainly with pediatric genetics. The most conspicuous public policies in genetics are newborn screening and folic acid fortification of flour. Genetics/genomics research is funded by state agencies and is conducted in several institutes and centers. Clinical genetics research occurs in public hospitals and deals primarily with congenital syndromes. While there are no defined government policies in the public application of genomics, there have been initiatives to improve the provision of clinical genetic services countrywide. The main hurdles for applying genetics in health care are a fragmented, inefficient, and inequitable health system, facing large unmet needs in infectious diseases, malnutrition, prenatal and newborn care, deficient education in genetics, and lack of explicit public policies in genetic health care and governmental regulations. Overcoming these obstacles requires increase in government funding and improvement of the efficiency of the public health system and its genetic services. Further, there must be concerted efforts to ensure equitable access to the latter. Interactions should be promoted between clinical geneticists, public health officers, primary health care personnel and parent/patient organizations on the use of genetics/genomics in public health, as well as genetics education of health professionals, the public and decision makers, and development of the capacity of the state to regulate properly the application of genetic/genomic technologies to public health.

Keywords:
Argentina, Clinical genetics services, Public health genetics and genomics, Public policies in genetics, Research in genetics and genomics
1.
Martínez-Marignac VL, Bertoni B, Parra EJ, Bianchi NO: Characterization of admixture in an urban sample from Buenos Aires, Argentina, using uniparentally and biparentally inherited genetic markers. Hum Biol 2004;76:543–557.
2.
Comisión Nacional sobre la Desaparición de Personas. Nunca Más (Never Again):A Report by Argentina’s National Commission on Disappeared People. London, Faber, 1986.
3.
World Bank. Available at http://devdata.worldbank.org.
4.
National University of La Plata, Center for Distributive, Labor and Social Studies. Available at www.depeco.econo.unlp.edu.ar/cedlas/ (Spanish).
5.
Pan American Health Organization: Health in the Americas: Argentina. Washington, DC, 2007, vol 2, pp 27–48.
6.
Argentina, Ministerio de Salud; Pan American Health Organization. Basic Indicators, Argentina 2007.
7.
Penchaszadeh VB, Beiguelman B: Medical genetics services in Latin America: Report of a meeting of experts. Pan Am J Public Health 1998;3:409–420.
8.
Castilla EE, Orioli IM: ECLAMC: the Latin-American collaborative study of congenital malformations. Community Genet 2004;7:76–94.
9.
Dodelson de Kremer R, Depetris de Boldini C, Paschini de Capra A, Pons de Veritier P, Goldenhersch H, Corbella L, Sembaj A, Martín S, Kremer I, Mass L, et al: Estimation of heterozygote frequency of Sandhoff disease in a high-risk Argentinian population. Predictive assignment of the genotype through statistical analysis. Medicina (B Aires) 1987;47:455–463.
10.
Castilla EE, Adams J: Genealogical information and the structure of rural Latin-American populations: reality and fantasy. Hum Hered 1996;46:241–255.
11.
Argentina. Ministerio de Salud. Comisión Nacional de Genética y Salud. Design and organization of a national network of medical genetics. 2007. Spanish. Unpublished. Available from the author.
12.
Barreiro C: Collaborative Study on Clinical Genetics. Argentina. Ministerio de Salud. Comisión Salud Investiga, 2007, Spanish. Available at http://www.msal.gov.ar/htm/site/salud_investiga/ecm.asp.
13.
Zamberlin N: Abortion in Argentina. Buenos Aires, CEDES/FEIM/IPPF, 2007, Spanish. Available at www.cedes.org.
14.
Gadow E, Petracchi F, Igarzabal L, Gadow A, Quadrelli R, Krupitzki H: Awareness and attitude toward prenatal diagnosis of chromosomal abnormalities in patients with no access to legal termination of pregnancy. Prenat Diagn 2006;10:885–891.
15.
Argentina, Ministerio de Salud. Newborn screening program, 2007, Spanish. Available at http://www.msal.gov.ar/htm/Site/promin/UCMISALUD/index.htm.
16.
City of Buenos Aires. Newborn screening data, 2007, Spanish. Available at http://buenosaires.gov.ar/areas/salud/redes/archivos/datos_estadisticas_ppn.pdf.
17.
Argentina. Ministerio de Salud. Text of the newborn screening law, 2007, Spanish. Available at http://test.e-legis-ar.msal.gov.ar/leisref/public/showAct.php?id=6601.
18.
Srebrow A, Kornblihtt AR: The connection between splicing and cancer. J Cell Sci 2006;119:2635–2641.
19.
Paladino N, Fainboim H, Theiler G, Schroder T, Muñoz AE, Flores AC, Galdame O, Fainboim L: Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol 2006;80:9144–9150.
20.
Dipierri JE, Alfaro E, Martínez-Marignac VL, Bailliet G, Bravi CM, Bianchi NO: Paternal directional mating in two Amerindian subpopulations located at different altitude in the Northwest of Argentina. Hum Biol 1998;70:1001–1010.
21.
Bianchi NO, Martínez-Marignac VL, Guanuco R: Identificación de Amerindios por medio del análisis de ADN. Su aplicación en los litigios por posesión de tierras, y otros temas legales y éticos. Interciencia 2003;28:1–8.
22.
Flores AC, Marcos CY, Paladino N, Capucchio M, Theiler G, Arruvito L, Pardo R, Habegger A, Williams F, Middleton D, Fainboim L: KIR genes polymorphism in Argentinean caucasoid and Amerindian populations. Tissue Antigens 2007;69:568–576.
23.
Marino M, Sala A, Corach D: Population genetic analysis of 15 autosomal STRs loci in the central region of Argentina.Forensic Sci Int 2006;161:72–77.
24.
Corach D, Filgueira Risso L, Marino M, Penacino G, Sala A: Routine Y-STR typing in forensic casework. Forensic Sci Int 2001;118:131–135.
25.
El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, et al: The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005;309:409–415.
26.
Podhajcer OL, Lopez MV, Mazzolini G: Cytokine gene transfer for cancer therapy. Cytokine Growth Factor Rev 2007;18:183–194.
27.
Avila JR, Jezewski PA, Vieira AR, Orioli IM, Castilla EE, Christensen K, Daack-Hirsch S, Romitti PA, Murray JC: PVRL1 variants contribute to non-syndromic cleft lip and palate in multiple populations. Am J Med Genet A 2006;140:2562–2570.
28.
Penchaszadeh VB: Genetic identification of children of the disappeared in Argentina. J Am Med Womens Assoc 1997;52:16–27.
29.
Equipo Argentino de Antropología Forense, 2007, Spanish. Available at http://desaparecidos.org/notas/2007/11/arg-eaaf-solicita-muestras-de.html.
30.
Torrado M, Araoz V, Baialardo E, Abraldes K, Mazza C, Krochik G, Ozuna B, Leske V, Caino S, Fano V, Chertkoff L: Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an interdisciplinary study. Am J Med Genet A 2007;143:460–468.
31.
Baialardo EM, Torrado Mdel V, Barreiro CZ, Gallego MS: Partial distal 5p trisomy resulting from paternal translocation (5;15) (p15.1;p13) in a boy with no mental retardation. Clin Dysmorphol 2003;12:257–259.
32.
Gallego MS, Zelaya G, Feliu AS, Rossetti L, Shaffer LG, Bailey KA, Bacino CA, Barreiro CZ: ATR-16 due to a de novo complex rearrangement of chromosome 16. Hemoglobin 2005;29:141–150.
33.
Fano V, Gravina LP, Pino MD, Chertkoff L, Barreiro C, Lejarraga H: High specificity of head circumference to recognize N540K mutation in hypochondroplasia. Ann Hum Biol 2005;32:782–788.
34.
Baranzini SE, Giliberto F, Dalamon V, Barreiro C, García-Erro M, Grippo J, Szijan I: Carrier detection in Duchenne and Becker muscular dystrophy Argentine families. Clin Genet 1998;54:503–511.
35.
Bonaventure G, Torrado M, Barreiro C, Chertkoff L: Fragile X founder effects in Argentina. Am J Med Genet 1998;79:200–204.
36.
Chertkoff L, Visich A, Bienvenu T, Grenoville M, Segal E, Carniglia L, Kaplan JC, Barreiro C: Spectrum of CFTR mutations in Argentine cystic fibrosis patients. Clin Genet 1997;51:43–47.
37.
Visich A, Zielenski J, Castaños C, Diez G, Grenoville M, Segal E, Barreiro C, Tsui LC, Chertkoff L: Complete screening of the CFTR gene in Argentine cystic fibrosis patients. Clin Genet 2002;61:207–213.
38.
Feliu-Torres A, Bonduel M, Schiuccati G, del Pozo A, Roldan A, Ciacio M, Orazi V, Fano V, Ozuna B, Lejarraga H, Sackmann-Muriel F: Beta talasemia en la Argentina. Medicina (B Aires) 2002;62:124–134.
39.
Gravina LP, Foncuberta ME, Estrada RC, Barreiro C, Chertkoff L: Carrier frequency of the 35delG and A1555G deafness mutations in the Argentinean population. Impact on the newborn hearing screening. Int J Pediatr Otorhinolaryngol 2007;71:639–643.
40.
Solano AR, Dourisboure RJ, Weitzel J, Podesta EJ: A cautionary note: false homozygosity for BRCA2 6174delT mutation resulting from a single nucleotide polymorphism masking the wt allele. Eur J Hum Genet 2002;10:395–397.
41.
Arbetman A, Abdala M, Fandiño A, Herrera J, Baranzini S, Borelina D, Parma D, Manzitti J, Barreiro C, Giliberto F, Szijan I: Clinical, cytogenetic, and molecular testing of Argentine patients with retinoblastoma. J AAPOS 1998;2:102–107.
42.
Belli S, Storani ME, Dourisboure RJ, Podestá EJ, Solano AR: Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers (Spanish). Medicina (B Aires) 2003;63:41–45.
43.
De Rosa M, Dourisboure RJ, Morelli G, Graziano A, Gutiérrez A, Thibodeau S, Halling K, Avila KC, Duraturo F, Podesta EJ, Izzo P, Solano AR: First genotype characterization of Argentinean FAP patients: identification of 14 novel APC mutations. Hum Mutat 2004;23:523–524.
44.
Penchaszadeh VB: Genetic services in Latin America. Community Genet 2004;7:65–69.
45.
Penchaszadeh VB, Christianson AL, Giugliani R, Boulyjenkov V, Katz M: Services for the prevention and management of genetic disorders and birth defects in developing countries. Community Genet 1999;2:196–201.
46.
Kofman-Alfaro S, Penchaszadeh VB: Community genetic services in Latin America and regional network of genetic services. Community Genet 2004;7:157–159.
47.
Pan American Health Organization. Recommendations for the development of genetics in public health in Latin America. Report of a meeting of experts. Rio de Janeiro, June 21, 2007. Unpublished document. Available from the author.
48.
Pan American Health Organization. Program on Genetics, Public Health and Human Rights. 2007. Unpublished document. Available from the author.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.